Benchling Launches Support for the Discovery and Development of RNA Therapeutics

SAN FRANCISCO: SAN FRANCISCO, June 22, 2021 /PRNewswire/ -- Benchling, the leading life sciences cloud, today announced the launch of a digital solution for scientists to design, analyze, and develop complex RNA therapeutics in a unified R&D platform for the first time. RNA therapeutics have the potential to transform treatment...

Click to view original post